| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Original Research Communications |
Background: Antiretroviral therapy has improved the prospects for people infected with HIV, but some develop a syndrome of profound body habitus and metabolic alterations that include truncal enlargement.
Objective: The purpose of this study was to define the body-composition changes associated with this syndrome by using techniques with the power to estimate regional body composition.
Design: We compared whole-body and regional skeletal muscle and adipose tissue contents measured by magnetic resonance imaging and dual-energy X-ray absorptiometry (DXA) in 26 HIV-infected patients and 26 matched control subjects. Twelve of the HIV-infected patients had evidence of truncal enlargement.
Results: HIV-infected men and women who noted truncal enlargement had similar amounts of skeletal muscle and subcutaneous adipose tissue but greater visceral adipose tissue than HIV-infected patients without truncal enlargement; these values were larger in men (P < 0.001) than in women (P = 0.08). The ratio of visceral to subcutaneous adipose tissue was greater in both men (P < 0.02) and women (P = 0.05) with truncal enlargement. Two subjects with MRI-confirmed visceral adiposity syndrome (VAS) were not taking protease inhibitors. CD4+ lymphocyte counts were higher (P < 0.001) and plasma viral burdens tended to be lower (P = 0.08) in HIV-infected patients with VAS.
Conclusions: There was significantly more visceral adipose tissue in the subgroup of HIV-infected patients with truncal enlargement than in those without this sign. VAS occurs in both men and women, is associated with higher CD4+ lymphocyte counts and lower plasma HIV viral burdens, and is not limited to those receiving protease inhibitor therapy.
Key Words: Adipose tissue • regional fat distribution • nutrition assessment • HIV infection • antiretroviral agents • protease inhibitors • magnetic resonance imaging • MRI • densitometry • dual-energy X-ray absorptiometry • DXA • body composition • visceral adiposity syndrome • syndrome X • truncal enlargement • body cell mass • humans
This article has been cited by other articles:
|
|
 |
|
  J. Fuller A 39-Year-Old Man With HIV-Associated Lipodystrophy JAMA, September 3, 2008; 300(9): 1056 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Perez-Molina, P. Domingo, E. Martinez, and S. Moreno The role of efavirenz compared with protease inhibitors in the body fat changes associated with highly active antiretroviral therapy J. Antimicrob. Chemother., August 1, 2008; 62(2): 234 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Falutz, S. Allas, K. Blot, D. Potvin, D. Kotler, M. Somero, D. Berger, S. Brown, G. Richmond, J. Fessel, et al. Metabolic Effects of a Growth Hormone-Releasing Factor in Patients with HIV N. Engl. J. Med., December 6, 2007; 357(23): 2359 - 2370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B Albu, S. Kenya, Q. He, M. Wainwright, E. S Berk, S. Heshka, D. P Kotler, and E. S Engelson Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women Am. J. Clinical Nutrition, July 1, 2007; 86(1): 100 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Peyrin-Biroulet, M. Chamaillard, F. Gonzalez, E. Beclin, C. Decourcelle, L. Antunes, J. Gay, C. Neut, J.-F. Colombel, and P. Desreumaux Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? Gut, April 1, 2007; 56(4): 577 - 583. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Aghdassi, B. Arendt, I. E. Salit, and J. P. Allard Estimation of Body Fat Mass Using Dual-Energy X-Ray Absorptiometry, Bioelectric Impedance Analysis, and Anthropometry in HIV-Positive Male Subjects Receiving Highly Active Antiretroviral Therapy JPEN J Parenter Enteral Nutr, March 1, 2007; 31(2): 135 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. He, E. S. Engelson, and D. P. Kotler A Comparison of Abdominal Subcutaneous Adipose Tissue Pattern in Obese and Lean HIV-Infected Women J. Nutr., January 1, 2005; 135(1): 53 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Koutkia, B. Canavan, J. Breu, M. L Johnson, A. Depaoli, and S. K Grinspoon Relation of leptin pulse dynamics to fat distribution in HIV-infected patients Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1103 - 1109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Johnson, J. B. Albu, E. S. Engelson, S. K. Fried, Y. Inada, G. Ionescu, and D. P. Kotler Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E261 - E271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M Hendricks, K. R Dong, A. M Tang, B. Ding, D. Spiegelman, M. N Woods, and C. A Wanke High-fiber diet in HIV-positive men is associated with lower risk of developing fat deposition Am. J. Clinical Nutrition, October 1, 2003; 78(4): 790 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. He, E. S. Engelson, J. B. Albu, S. B. Heymsfield, and D. P. Kotler Preferential loss of omental-mesenteric fat during growth hormone therapy of HIV-associated lipodystrophy J Appl Physiol, May 1, 2003; 94(5): 2051 - 2057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chen, A. Misra, and A. Garg Lipodystrophy in Human Immunodeficiency Virus-Infected Patients J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4845 - 4856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Meininger, C. Hadigan, P. Rietschel, and S. Grinspoon Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men Am. J. Clinical Nutrition, August 1, 2002; 76(2): 460 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Andrade, S. J. J Lan, E. S Engelson, D. Agin, J. Wang, S. B Heymsfield, and D. P Kotler Use of a Durnin-Womersley formula to estimate change in subcutaneous fat content in HIV-infected subjects Am. J. Clinical Nutrition, March 1, 2002; 75(3): 587 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Y. McDermott, A. Shevitz, T. Knox, R. Roubenoff, J. Kehayias, and S. Gorbach Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women Am. J. Clinical Nutrition, November 1, 2001; 74(5): 679 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schwenk, A. Beisenherz, K. Romer, G. Kremer, B. Salzberger, and M. Elia Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment Am. J. Clinical Nutrition, August 1, 2000; 72(2): 496 - 501. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
